About | Free Trial

Last Update

2016-06-17T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Barbara White?

Dr. Barbara White J. MD

Chief Medical Officer

Corbus LLC

HQ Phone: (888) 608-9975

Email: b***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Corbus LLC

The Exchange 2835 Miami Village Drive

Miamisburg, Ohio 45342

United States

Company Description

Corbus, LLC, a global solutions provider founded in 1994, offers superior services combining years of experience, solid partnerships and adaptability. Corbus solution offering includes Information Technology and Sourcing and Procurement services. Corbus c ... more

Find other employees at this company (598)

Background Information

Employment History

Sclero Forums

Chief Medical Officer

Corbus Pharmaceuticals Holdings, Inc.

Clinical Project Manager

FoldRx Pharmaceuticals Inc

Associate Professor of Medicine

University of Maryland

Co-Director

Johns Hopkins University

Senior Vice President and Head of Research and Development

Stiefel Laboratories , Inc.

M.D., Vice President, Therapeutic Area Immunology, Global Projects and Development

UCB S.A

Head, Global Research and Development

MedImmune , Inc.

Associate Chief of Staff of the Research Service

Baltimore Veteran Administration Medical Center

Affiliations

Board Member
American College of Rheumatology

Ad Hoc Member of the Arthritis Advisory Committee
Food and Drug Administration

Education

University of Maryland

MD

medical degree

University

medical degree

University of Pennsylvania School of Medicine

Web References (182 Total References)


Additionally, we will be collecting data ...

globalpharmaupdate.com [cached]

Additionally, we will be collecting data on safety and efficacy of Resunab in systemic sclerosis in the open-label extension phase of this study," stated Barbara White, M.D., Chief Medical Officer of Corbus.


Overview :: Corbus Pharmaceuticals Holdings, Inc. (CRBP)

ir.corbuspharma.com [cached]

Barbara White, MD

Chief Medical Officer
Barbara White, M.D., joined Corbus as Chief Medical Officer in June 2014. Dr. White's industry experience includes Phase 1-4 clinical development experience in inflammatory and autoimmune diseases, including rheumatology, respiratory, and View Full Bio


Management Team :: Corbus Pharmaceuticals Holdings, Inc. (CRBP)

ir.corbuspharma.com [cached]

Barbara White, MD

...
Barbara White, MD Chief Medical Officer
Barbara White, M.D., joined Corbus as Chief Medical Officer in June 2014. Dr. White's industry experience includes Phase 1-4 clinical development experience in inflammatory and autoimmune diseases, including rheumatology, respiratory, and dermatology diseases. She also has industry experience in pre-clinical drug development, translational medicine and medical affairs. Prior to joining Corbus, Dr. White was Senior Vice President and Head of R&D at Stiefel, a GSK company. She has held roles at UCB, MedImmune and Amgen. Prior to her pharmaceutical career, Dr. White was professor of medicine and Vice Chair for Research, Department of Medicine, at the University of Maryland School of Medicine. Her research has focused on T cells and immune-mediated mechanisms of lung fibrosis in scleroderma. She also previously served as co-director of the Johns Hopkins University and University of Maryland Scleroderma Center. Dr. White received her medical degree from the University of Pennsylvania School of Medicine and is board certified in internal medicine, rheumatology and allergy/clinical immunology. She completed her postdoctoral studies in basic cellular immunology at the National Institutes of Health.


Corbus Pharmaceuticals Holdings, Inc. (CRBP) News

ir.corbuspharma.com [cached]

"Resunab has demonstrated efficacy in pre-clinical models of inflammation and fibrosis, including a CF model, and to date, has a promising clinical safety profile in Phase 1 and 2 testing in humans," added Barbara White, M.D., Chief Medical Officer of the Company.

...
"Patient dosing has commenced as planned in our CF trial and we are on track to report top-line Resunab safety and efficacy data in the CF patient population at the end of 2016," commented Barbara White, M.D., Chief Medical Officer of the Company.
...
As a CB2 agonist, Resunab has the potential to be a disease-modifying agent in systemic sclerosis, by resolving inflammation and stopping further fibrosis, without immunosuppression," commented Barbara White, M.D., Chief Medical Officer of the Company.
...
Barbara White, M.D., Chief Medical Officer of the Company, commented, "The start of the CF study is an important clinical development milestone for Resunab.
...
Barbara White, M.D., Chief Medical Officer of the Company, commented, "The launch of this study is an important milestone in the clinical development of Resunab.
...
Barbara White, M.D., Chief Medical Officer of the Company, added, "The dosing of the first subject in this dermatomyositis trial marks an important milestone in our Resunab clinical development program.
...
"We are grateful for this opportunity to work in close collaboration with Dr. Werth and the NIH to test the safety and efficacy of Resunab in dermatomyositis in this Phase 2 trial," commented Barbara White, M.D., Chief Medical Officer of the Company.


Management Team :: Corbus Pharmaceuticals Holdings, Inc. (CRBP)

www.corbuspharma.com [cached]

Barbara White, MD

...
Barbara White, MD Chief Medical Officer
Barbara White, M.D., joined Corbus as Chief Medical Officer in June 2014. Dr. White's industry experience includes Phase 1-4 clinical development experience in inflammatory and autoimmune diseases, including rheumatology, respiratory, and dermatology diseases. She also has industry experience in pre-clinical drug development, translational medicine and medical affairs. Prior to joining Corbus, Dr. White was Senior Vice President and Head of R&D at Stiefel, a GSK company. She has held roles at UCB, MedImmune and Amgen. Prior to her pharmaceutical career, Dr. White was professor of medicine and Vice Chair for Research, Department of Medicine, at the University of Maryland School of Medicine. Her research has focused on T cells and immune-mediated mechanisms of lung fibrosis in scleroderma. She also previously served as co-director of the Johns Hopkins University and University of Maryland Scleroderma Center. Dr. White received her medical degree from the University of Pennsylvania School of Medicine and is board certified in internal medicine, rheumatology and allergy/clinical immunology. She completed her postdoctoral studies in basic cellular immunology at the National Institutes of Health.

Similar Profiles

Other People with this Name

Other people with the name White

Jaime White
Dr. Jaime White

Jason White
Brass House Austin

Helen White
AgriLife

Richard White
Re/max Allegiance

Thomas White

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory